NCT04745104View on ClinicalTrials.gov

A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions
Alzheimer Disease
Interventions
DRUG

SHR-1707

SHR-1707 will be administered through IV infusion

DRUG

Placebo

Placebo will be administered through IV infusion

Trial Locations (1)

2000

Atridia Pty Limited, Sydney

All Listed Sponsors
lead

Atridia Pty Ltd.

INDUSTRY

NCT04745104 - A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects | Biotech Hunter | Biotech Hunter